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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 73, Revision 1 
(FGE.73Rev1): 
Consideration of alicyclic primary alcohols, aldehydes, acids and related 
esters evaluated by JECFA (59th meeting) structurally related to primary 
saturated or unsaturated alicyclic alcohol, aldehyde, and esters evaluated 
by EFSA in FGE.12Rev2 (2011)1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
 
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to consider evaluations of flavouring substances assessed since 
2000 by the Joint FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide 
whether further evaluation is necessary, as laid down in Commission Regulation (EC) No 1565/2000. 
The present consideration concerns a group of 16 alicyclic primary alcohols, aldehydes, acids and 
related esters evaluated by the JECFA at the 59th meeting in 2002. The revision is made due to 
consideration of one additional substance compared to the previous version. The substances were 
evaluated through a stepwise approach that integrates information on structure-activity relationships, 
intake from current uses, toxicological threshold of concern, and available data on metabolism and 
toxicity. The Panel agrees with the application of the Procedure as performed by the JECFA for all 16 
                                                     
 
1  On request from the European Commission, Question No EFSA-Q-2010-01249, adopted on 22 March 2012. 
2 Panel members: Ulla Beckman Sundh, Mona-Lise Binderup, Leon Brimer, Laurence Castle, Karl-Heinz Engel, Roland 
Franz, Nathalie Gontard, Rainer Gürtler, Trine Husøy, Klaus-Dieter Jany, Catherine Leclercq, Jean Claude Lhuguenot, 
Wim Mennes, Maria Rosaria Milana, Iona Pratt, Kettil Svensson, Fidel Toldra, Detlef Wölfle. Correspondence: 
cef@efsa.europa.eu. 
3 Acknowledgement: The Panel wishes to thank the members of the Working Group on Flavourings for the preparation of 
this Opinion: Ulla Beckman Sundh, Vibe Beltoft, Leon Brimer, Wilfried Bursch, Angelo Carere, Karl-Heinz Engel, 
Henrik Frandsen, Rainer Gürtler, Frances Hill, Trine Husøy, John Christian Larsen, Pia Lund, Wim Mennes, Gerard 
Mulder, Karin Nørby, Gerrit Speijers, Harriet Wallin and EFSA’s staff member Kim Rygaard Nielsen for the preparatory 
work on this scientific Opinion. 
 
Flavouring Group Evaluation 73, Revision 1
 
EFSA Journal 2012;10(3):2638 2
substances [FL-no: 02.114, 02.141, 05.098, 05.104, 05.112, 05.119, 05.123, 08.034, 08.060, 08.067, 
09.028, 09.289, 09.488, 09.534, 09.536 and 09.615], considered in this FGE and agrees with the 
JECFA conclusion, “No safety concern at estimated levels of intake as flavouring substances” based 
on the MSDI approach. Besides the safety assessment of these flavouring substances, the 
specifications for the materials of commerce have also been considered and for all 16 substances, the 
information is adequate. 
© European Food Safety Authority, 2012 
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SUMMARY 
The Scientific Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) was asked to give scientific advice to the Commission on the implications for human health of 
chemically defined flavouring substances used in or on foodstuffs in the Member States. In particular, 
the Panel was requested to consider the Joint FAO/WHO Expert Committee on Food Additives (the 
JECFA) evaluations of flavouring substances assessed since 2000, and to decide whether no further 
evaluation is necessary, as laid down in Commission Regulation (EC) No 1565/2000. These 
flavouring substances are listed in the Register, which was adopted by Commission Decision 
1999/217/EC and its consecutive amendments. 
The revision is made due to consideration of one additional substance, 2,6,6-trimethylcyclohexa-1,3-
diene-1-carbaldehyde [FL-no: 05.104], compared to the previous version of FGE.73. This substance 
has been evaluated in FGE.209 due to structural concern for genotoxicity, and has been cleared from 
this concern and thus may be evaluated through the Procedure.   
The present consideration therefore concerns 16 alicyclic primary alcohols, aldehydes, acids and 
related esters evaluated by the JECFA (59th meeting) and will be considered in relation to the 
European Food Safety Authority (EFSA) evaluation of nine primary saturated or unsaturated alicyclic 
alcohol, aldehyde and esters evaluated in the Flavouring Group Evaluation 12, Revision 2 
(FGE.12Rev2). 
A further 10 substances were evaluated by the JECFA in this group, one substance is not in the 
Register [mixture of 2-methyl-5-(2,3-dimethyltricyclo[2.2.1.0(2.6)]hept-3-yl)pent-2-en-1-ol and 2-
methyl-5-(2-methyl-3-methylenebicyclo[2.2.1]hept-2-yl)pent-2-en-1-ol] (JECFA no: 984) and nine 
substances are alpha,beta-unsaturated aldehydes or precursors for such [FL-no: 02.060, 02.091, 
05.106, 05.117, 05.121, 09.034, 09.272, 09.278 and 09.302]. The genotoxicity properties of these nine 
substances were considered together with other alpha,beta-unsaturated aldehydes and ketones in 
FGE.208 for which it was concluded that additional data were required. 
The Panel agrees with the application of the Procedure as performed by the JECFA for the 16 
substances considered in this FGE. 
For all 16 substances evaluated through the Procedure use levels are needed to calculate the modified 
Theoretical Added Maximum Daily Intake (mTAMDI) in order to identify those flavouring substances 
that need more refined exposure assessment and to finalise the evaluation. 
In order to determine whether the conclusion for the 16 JECFA evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity tests are available for all 16 JECFA 
evaluated substances.  
Thus, for all 16 substances [FL-no: 02.114, 02.141, 05.098, 05.104, 05.112, 05.119, 05.123, 08.034, 
08.060, 08.067, 09.028, 09.289, 09.488, 09.534, 09.536 and 09.615] the Panel agrees with the JECFA 
conclusion “No safety concern at estimated levels of intake as flavouring substances” based on the 
MSDI approach. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances, the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a).  
Commission Regulation (EC) No 1565/2000 lays down that substances that are contained in the 
Register and will be classified in the future by the Joint FAO/WHO Expert Committee on Food 
Additives (the JECFA) so as to present no safety concern at current levels of intake will be considered 
by the European Food Safety Authority (EFSA), who may then decide that no further evaluation is 
necessary. 
In the period 2000 – 2008, during its 55th, 57th, 59th, 61st, 63rd, 65th, 68th and 69th meetings, the JECFA 
evaluated about 1000 substances, which are in the EU Register. 
TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to consider the Joint FAO/WHO Expert 
Committee on Food Additives (the JECFA) evaluations of flavouring substances assessed since 2000, 
and to decide whether no further evaluation is necessary, as laid down in Commission Regulation (EC) 
No 1565/2000 (EC, 2000a). These flavouring substances are listed in the Register, which was adopted 
by Commission Decision 1999/217/EC (EC, 1999a) and its consecutive amendments. 
The evaluation programme was finalised at the end of 2009. 
After the finalisation of the evaluation programme, in their letter of the 7th September 2010, the 
Commission requested EFSA, based on additional submitted data on genotoxicity, to carry out re-
evaluation of the flavouring substance 2,6,6-trimethylcyclohexa-1,3-diene-1-carbaldehyde [FL-no: 
05.104] and depending on the outcome to proceed to the evaluation of this flavouring substance 
through the Procedure, also according to Commission Regulation (EC) No 1565/2000 (EC, 2000a). 
ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), hereafter named the “EFSA Procedure”. 
This Procedure is based on the Opinion of the Scientific Committee on Food (SCF, 1999a), which has 
been derived from the evaluation procedure developed by the Joint FAO/WHO Expert Committee on 
Food Additives (JECFA, 1995; JECFA, 1996a; JECFA, 1997a; JECFA, 1999b), hereafter named the 
“JECFA Procedure”. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing 
Aids (the Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be put through the EFSA Procedure. 
The following issues are of special importance. 
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Intake 
In its evaluation, the Panel as a default uses the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA, at its 65th meeting 
considered ”how to improve the identification and assessment of flavouring agents, for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods” (JECFA, 2006c). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a “modified Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 Microgram/Person/Day (Step B5) Used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram/person/day as part of the evaluation 
procedure: 
“The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 microgram per 
person per day would not be expected to present a safety concern. The Committee recommended that 
the Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be 
amended to include the last step on the right-hand side of the original Procedure (“Do the condition of 
use result in an intake greater than 1.5 microgram per day?”) (JECFA, 1999b).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 microgram per person per day. 
 
 
Genotoxicity 
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As reflected in the Opinion of SCF (SCF, 1999a), the Panel has in its evaluation focussed on a 
possible genotoxic potential of the flavouring substances or of structurally related substances. 
Generally, substances for which the Panel has concluded that there is an indication of genotoxic 
potential in vitro, will not be evaluated using the EFSA Procedure until further genotoxicity data are 
provided. Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated 
through the Procedure. 
Specifications 
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of 
JECFA, since the Panel requests information on e.g. isomerism. 
Structural Relationship  
In the consideration of the JECFA evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
HISTORY OF THE EVALUATION OF THE SUBSTANCES IN THE PRESENT FGE 
In FGE.73, which contains a group of 15 alicyclic primary alcohols, aldehydes, acids and related 
esters, the Panel considered that for nine substances [FL-no: 02.114, 02.141, 05.098, 05.112, 08.067, 
09.289, 09.488, 09.534 and 09.615] additional data were needed (no European production volumes 
available, preventing them to be evaluated using the Procedure, and/or missing data on 
isomerism/composition). For the remaining six of the 15 JECFA evaluated substances [FL-no: 05.119, 
05.123, 08.034, 08.060, 09.028 and 09.536] the Panel agreed with the JECFA conclusion “no safety 
concern at estimated levels of intake as flavouring substances” based on the MSDI approach. 
FGE Opinion adopted 
by EFSA 
Link No. of 
candidate 
substances 
FGE.73 6 March 2008 http://www.efsa.europa.eu/en/efsajournal/pub/868.htm 15 
FGE.73Rev1 22 March 2012  16 
 
The present revision of FGE.73, FGE.73Rev1, includes the consideration of one additional substance 
[FL-no: 05.104]. The substance is a cyclic aldehyde with the conjugated alpha,beta-double bond 
incorporated in the ring system and was originally allocated to FGE.209 (EFSA, 2011d) in which the 
Panel concluded that the data available ruled out the concern for genotoxicity and thus concluded that 
this substance could be evaluated through the Procedure. The information concerning genotoxicity of 
this substance is described in Section 3.3. A search in open literature for the new substance did not 
provide any further data on toxicity or metabolism. 
Since the publication of FGE.73, the EU production volume has been provided for three substances, 
[FL-no: 02.141, 09.488 and 09.534] for which the evaluation could not be finalised in the previous 
version of this FGE, due to lack of these data. Based on the newly submitted EU production volume 
the substances have already been evaluated in FGE.964 (EFSA, 2011al) (Concerning FGE.73: “For the 
three substances the Panel concluded at step A3 that these substances would be of no safety concern at 
their estimated level of intake based on the MSDI approach”), but for the sake of completion, the 
information has been included in the present revision of FGE.73 as well. 
                                                     
 
4 Scientific Opinion on Flavouring Group Evaluation 96 (FGE.96), addendum to FGE. 51, 52, 53, 54, 56, 58, 61, 62, 63, 64, 
68, 69, 70, 71, 73, 76, 77, 79, 80, 83, 84, 85 and 87: Consideration of 88 flavouring substances considered by EFSA for 
which EU production volumes / anticipated production volumes have been submitted on request by DG SANCO). 
Flavouring Group Evaluation 73, Revision 1
 
EFSA Journal 2012;10(3):2638 8
Finally, new information on the stereoisomeric composition has been provided for six substances [FL-
no: 02.114, 02.141, 05.098, 08.067, 09.289 and 09.615] and for one substance [FL-no: 05.112] further 
information on the composition has been submitted, since the previous version of FGE.73 (EFFA, 
2010a). 
1. Presentation of the Substances in the JECFA Flavouring Group 
1.1. Description 
1.1.1. JECFA Status 
The JECFA has at the 59th meeting evaluated a group of 26 flavouring substances consisting of 
alicyclic primary alcohols, aldehydes, acids and related esters (JECFA, 2003a).  
1.1.2. EFSA Considerations 
One of the 26 JECFA evaluated substances is not in the Register [Mixture of 2-methyl-5-(2,3-
dimethyltricyclo[2.2.1.0(2,6)]hept-3-yl)pent-2-en-1-ol and 2-methyl-5-(2-methyl-3-methylenebicyclo 
[2.2.1]hept-2-yl)pent-2-en-1-ol] (JECFA-no: 984).  
Ten substances [FL-no: 02.060, 02.091, 05.104, 05.106, 05.117, 05.121, 09.034, 09.272, 09.278 and 
09.302] are alpha,beta-unsaturated aldehydes or may be metabolised to alpha,beta-unsaturated 
aldehydes and have been considered together with other alpha,beta-unsaturated aldehydes and ketones. 
One of these alpha,beta-unsaturated substances [FL-no: 05.104] has been considered with respect to 
genotoxicity in FGE.209 (EFSA, 2011d), and the Panel concluded that the data available ruled out the 
concern for genotoxicity and thus concluded that this substance can be evaluated through the 
Procedure in this revision of FGE.73. The genotoxic properties of the remaining nine of these 10 
alpha,beta-unsaturated carbonyl substances were considered together with other alpha,beta-unsaturated 
aldehydes and ketones in FGE.208 (EFSA, 2008b) for which it was concluded that additional data 
were required for all nine substances. 
This consideration will therefore deal with 16 JECFA evaluated substances. The Panel concluded that 
the 16 substances in the JECFA flavouring group of alicyclic primary alcohols, aldehydes, acids and 
related esters are structurally related to the group of primary saturated or unsaturated alicyclic alcohol, 
aldehyde and esters evaluated by EFSA in the Flavouring Group Evaluation 12, Revision 2 
(FGE.12Rev2). 
1.2. Isomers 
1.2.1. Status 
Eight substances in the group of the JECFA evaluated alicyclic primary alcohols, aldehydes, acids and 
related esters have one or more chiral centres [FL-no: 02.114, 02.141, 05.098, 05.119, 05.123, 08.067, 
09.289 and 09.615]. 
1.2.2. EFSA Considerations 
In FGE.73, information was lacking about stereoisomerism for six of these eight substances [FL-no: 
02.114, 02.141, 05.098, 08.067, 09.289 and 09.615]. After publication of FGE.73, Industry has 
specified the stereoisomeric composition (EFFA, 2010a).  
For the two stereoisomeric substances [FL-no: 05.119 and 05.123], the CAS register number (CASrn) 
is considered to specify the stereoisomeric composition Table 1). 
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1.3. Specifications 
1.3.1. JECFA Status 
The JECFA specifications are available for all 16 substances (JECFA, 2002d). See Table 1. 
1.3.2. EFSA Considerations 
The available specifications are considered adequate for all 16 substances (See Section 1.2). 
2. Intake Estimations 
2.1. JECFA Status 
For all 16 substances evaluated through the JECFA Procedure intake data are available for the EU, see 
Table 3.1. 
2.2. EFSA Considerations 
Tonnage data are available for the EU allowing calculation of the intake estimates (MSDI). The Panel 
noted that since no use levels were submitted no mTAMDI values can be calculated.  
3. Genotoxicity Data 
3.1. Genotoxicity Studies - Text Taken5 from the JECFA (JECFA, 2003a) 
No data on genotoxicity were available for the JECFA-evaluated substances. As these substances are 
rapidly metabolised in vivo to compounds of lower toxicological potential, the Committee concluded 
that the monocyclic and bicyclic terpenes with alkyl ring substituents and containing an alcohol, 
aldehyde or carboxylic acid group would have little genotoxic potential in vivo. 
3.2. Genotoxicity Studies - Text Taken6 from EFSA FGE.12Rev2 (EFSA, 2010x) 
There are no studies available on genotoxicity neither for the nine candidate substances nor for the 15 
supporting substances. The genotoxic potential of this group of flavouring substances can therefore 
not be assessed properly. However, this does not preclude evaluation of the candidate substances in 
the present group using the Procedure. 
3.3. Genotoxicity Studies - Text Taken7 from EFSA FGE.209 (EFSA, 2011d) 
The Industry has submitted data concerning genotoxicity studies for 2,6,6-trimethylcyclohexa-1,3-
diene-1-carbaldehyde [FL-no: 05.104] (safranal), which is the only substance considered in FGE.209. 
In Vitro Data 
In vitro genotoxicity assays have been performed on the alpha,beta-unsaturated aldehyde safranal [FL-
no: 05.104]. 
Bacterial Reverse Mutation Assay 
                                                     
 
5 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
6 The text is taken verbatim from the indicated reference source. 
7 The text is taken verbatim from the indicated reference source. 
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Safranal has been tested for its ability to induce gene mutations in the bacterial reverse mutation assay 
according to OECD guideline 471 (Beevers, 2010b) (for details see Table 2.4). The concentrations 
used in the different experiments were based on concentrations observed to give toxic effects in 
previous experiments. Positive and negative controls were included in all experiments according to 
current guidelines. 
There were some increases in revertant numbers in TA102 in the absence and presence of S9 in the 
first experiment, but these were of insufficient magnitude to be considered as evidence of 
mutagenicity, they were not concentration-related, and were not reproducible in the other experiments. 
In all other strains there was no evidence of mutagenic activity either in the absence or presence of S9 
in any of the experiments. 
It is concluded that under the test conditions applied safranal did not induce gene mutations in 
bacteria. 
Micronucleus Assays 
Safranal was evaluated in an in vitro micronucleus assay in human peripheral blood lymphocytes for 
its ability to induce chromosomal damage or aneuploidy in the presence and absence of S9 (Whitwell, 
2010c). The maximum soluble concentration of 1250 μg/ml was selected as the maximum 
concentration for the cytotoxicity range finder test. The concentrations in the main tests were based on 
toxicity shown in this range finding study (for details see Table 2.4).  
At the highest concentration used in the 3+21 hour treatment in the presence of S9, a small statistical 
increase in the frequency of micronucleated binucleate cells (MNBN) was observed, but this was set 
against a low mean concurrent vehicle control response. This concentration induced 62 % cytotoxicity, 
and there was no statistically significant increase in MNBN at the next lowest concentration, which 
induced 42 % cytotoxicity. Therefore, this isolated increase was not considered to be of biological 
importance. Outside of this isolated observation at a high level of toxicity, no evidence of 
chromosomal damage or aneuploidy was observed in terms of any increase in the frequency of MNBN 
in the presence or absence of S9.  
It is concluded that under the conditions of this study, safranal did not induce micronuclei in cultured 
human lymphocytes. 
In Vivo Data 
Based on the in vitro data available no in vivo data are needed. 
Discussion of Mutagenicity/Genotoxicity Data 
2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde [FL-no: 05.104] was tested for all three genetic 
endpoints: gene mutations, structural and numerical chromosomal aberrations. The substance did not 
induce gene mutations in bacteria and was not clastogenic and/or aneugenic in mammalian cells in 
vitro.  
For validation and study results see Table 2.1. 
Conclusion on Genotoxicity and Carcinogenicity 
The in vitro genotoxicity data on 2,6,6-trimethylcyclohexa-1,3-diene-1-carbaldehyde [FL-no: 05.104] 
do not indicate genotoxic potential. 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde [FL-no: 
05.104] will then be evaluated through the Procedure in FGE.73Rev1. 
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3.4. EFSA Considerations 
The present revision of FGE.73, Revision 1, contains 16 substances, one substance [FL-no: 05.104] 
has been added. This substance has a structural alert for genotoxicity, but this concern has been 
alleviated as shown in FGE.209. Therefore, this substance can also be evaluated through the 
Procedure. No genotoxicity data are available for the remaining 15 JECFA evaluated substances. 
However, this will not preclude the evaluation of these substances using the Procedure, and the Panel 
agreed with the JECFA that these 15 substances can be evaluated using the Procedure. 
4. Application of the Procedure 
4.1. Application of the Procedure to 16 Alicyclic Primary Alcohols, Aldehydes, Acids and 
Related Esters by the JECFA (JECFA, 2003a) 
According to the JECFA all 16 substances belong to structural class I using the decision tree approach 
presented by Cramer et al. (Cramer et al., 1978). 
The JECFA concluded for 15 of the alicyclic primary alcohols, aldehydes, acids and related esters at 
step A3 in the JECFA Procedure – i.e. the substances are expected to be metabolised to innocuous 
products (step 2) and the intakes for all substances are below the thresholds for their structural class I 
(step A3). 
The JECFA concluded for 2,6,6-trimethylcyclohexa-1,3-diene-1-carbaldehyde [FL-no: 05.104] 
(safranal) at step B4 in the JECFA Procedure – i.e. the substance cannot be expected to be metabolised 
to innocuous products (step 2) and an adequate NOAEL exists to provide a margin of safety (step B4). 
This evaluation was reached by the following procedure: Step B3. The daily per capita intake of the 
monocyclic substance with two endocyclic double-bonds evaluated at this step, 2,6,6-
trimethylcyclohexa-1,3-diene-1-carbaldehyde [FL-no: 05.104], was below the threshold for daily 
human intake of compounds of structural class I, and its evaluation therefore proceeded to step B4. 
Step B4. As the agent evaluated at this step, 2,6,6-trimethylcyclohexa-l,3-diene-1-carbaldehyde [FL-
no: 05.104] (safranal), is structurally related to perillyl alcohol [FL-no: 02.060], data on the toxicity of 
perillyl alcohol were used to evaluate its safety. Perillyl alcohol given by intragastric gavage changed 
the weights of several organs in female rats when given at 400 mg/kg bw per day, but not at 120 
mg/kg bw per day, in a 90-day study; changes in organ weights were not reported in male rats. Doses 
of 40, 120 and 400 mg/kg bw per day produced hyperexcitability and salivation, which the authors 
considered may have been due to its irritating properties (National Cancer Institute, 1996). A daily 
dose of 120 mg/kg bw was well tolerated by dogs in a 90-day study (National Cancer Institute, 1996). 
The daily intake of 2,6,6-trimethylcyclohexa-1,3-diene-1-carbaldehyde [FL-no: 05.104] (safranal) is 
0.058 microg/kg bw in Europe and 0.001 microg/kg bw in the USA. The margin of safety between 
these intakes and 120 mg/kg bw per day is > 2000000. The compound also shares structural 
similarities with alpha-ionone and beta-ionone [FL-no: 07.007] and [FL-no: 07.008], which were 
evaluated by the Committee at its fifty-first meeting (JECFA, 2000a). The NOELs for these 
compounds were 10 mg/kg bw per day in a 90-day study in rats, providing a margin of safety of about 
200000. Therefore, 2,6,6-trimethylcyclohexa-1,3-diene-1-carbaldehyde [FL-no: 05.104] (safranal) 
would not be a safety concern. 
In conclusion, the JECFA evaluated all 16 substances as to be of no safety concern at the estimated 
levels of intake as flavouring substances based on the MSDI approach. 
The evaluations of the 16 substances are summarised in Table 3.1: Summary of Safety Evaluation of 
Alicyclic Primary Alcohols, Aldehydes, Acids and Related Esters (JECFA, 2003a). 
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4.2. Application of the Procedure to Nine Primary Saturated or Unsaturated Alicyclic 
Alcohol, Aldehyde, and Esters by EFSA in FGE.12Rev2 (EFSA, 2010x) 
Nine candidate substances were evaluated in FGE.12Rev2. All nine substances were classified into 
structural class I, using the decision tree approach presented by Cramer et al. (Cramer et al., 1978). 
It was anticipated that all nine substances will be metabolised to innocuous products at the estimated 
levels of intake and accordingly proceed via the A-side of the Procedure. The estimated daily per 
capita intakes of the nine substances range from 0.011 to 43 microgram, which is below the threshold 
of concern of 1800 microgram/person/day for structural class I. 
The Panel concluded all substances in FGE.12Rev2 at step A3 as to be of no safety concern at the 
estimated levels of intake as flavouring substances based on the MSDI approach. 
The stepwise evaluations of the nine substances are summarised in Table 3.2: Summary of Safety 
Evaluation Applying the Procedure (EFSA, 2010x). 
4.3. EFSA Considerations 
The Panel agrees with the application of the Procedure as performed by the JECFA for the 16 
substances in the group of alicyclic primary alcohols, aldehydes, acids and related esters.  
The Panel noted that one substance [FL-no: 05.123] has a terminal double bond. Although 
theoretically, the double bond may be oxidised to give reactive epoxides, it is expected that for this 
substance, the metabolism via this pathway is negligible. The terminal double bond is present in a 
molecule that has an aldehyde function at the end distal from the double bond. The aldehyde function 
is expected to be readily attacked by oxidation processes, ultimately yielding unsaturated carboxylic 
acids. Biochemical attack of these carboxylic acids via e.g. beta-oxidation or conjugation with 
glucuronic acid is expected to be much more efficient and rapid than microsomal oxidation. 
5. Conclusion 
This consideration deals with 16 flavouring substances, which belong to a group of 26 alicyclic 
primary alcohols, aldehydes, acids and related esters evaluated by the JECFA of at the 59th meeting in 
2002. One substance is not in the Register [Mixture of 2-methyl-5-(2,3-
dimethyltricyclo[2.2.1.0(2,6)]hept-3-yl)pent-2-en-1-ol and 2-methyl-5-(2-methyl-3-methylenebicyclo 
[2.2.1]hept-2-yl)pent-2-en-1-ol] (JECFA-no: 984). Ten substances [FL-no: 02.060, 02.091, 05.104, 
05.106, 05.117, 05.121, 09.034, 09.272, 09.278 and 09.302] are alpha,beta-unsaturated aldehydes or 
may be metabolised to alpha,beta-unsaturated aldehydes. The genotoxic properties of nine of these 10 
substances were considered together with other alpha,beta-unsaturated aldehydes and ketones in 
FGE.208 for which it was concluded that additional data were required. The remaining alpha,beta-
unsaturated substance [FL-no: 05.104] has been considered with respect to genotoxicity in FGE.209 
(EFSA, 2011d), and the Panel concluded that the data available ruled out the concern for genotoxicity 
and thus concluded that this substance can be evaluated through the Procedure in this revision of 
FGE.73. No genotoxicity data are available for the remaining 15 JECFA evaluated substances. 
However, this will not preclude the evaluation of these substances using the Procedure.  
The Panel concluded that the 16 substances are structurally related to the group of nine primary 
saturated or unsaturated alicyclic alcohol, aldehyde and esters evaluated by EFSA in the Flavouring 
Group Evaluation 12, Revision 2 (FGE.12Rev2).  
The Panel agrees with the application of the Procedure as performed by the JECFA for the 16 
substances considered in this FGE. 
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For all 16 substances evaluated through the Procedure use levels are needed to calculate the 
mTAMDIs in order to identify those flavouring substances that need more refined exposure 
assessment and to finalise the evaluation. 
In order to determine whether the conclusion for the 16 JECFA evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity tests are available for all 16 JECFA 
evaluated substances.  
Thus, for all 16 substances [FL-no: 02.114, 02.141, 05.098, 05.104, 05.112, 05.119, 05.123, 08.034, 
08.060, 08.067, 09.028, 09.289, 09.488, 09.534, 09.536 and 09.615] the Panel agrees with the JECFA 
conclusion “No safety concern at estimated levels of intake as flavouring substances” based on the 
MSDI approach. 
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TABLE 1: SPECIFICATION SUMMARY  
Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of Alicyclic Primary Alcohols, Aldehydes, Acids and Related Esters (JECFA, 2002d) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
02.114 
970 
2-(2,2,3-Trimethylcyclopent-3-
enyl)ethan-1-ol 
OH  
3741 
 
1901-38-8 
Liquid 
C10H18O 
154.25 
Slightly soluble 
Miscible 
74 (0.8 hPa) 
 
NMR 
96 % 
1.470-1.478 
0.882-0.894 
(20°) 
 
Racemate (EFFA, 2010a). 
Synonym (+/-)-campholene 
alcohol (EFFA, 2010a).  
02.141 
986 
2-(6,6-Dimethylbicyclo[3.1.1]hept-2-
en-2-yl)ethan-1-ol 
OH  
3938 
 
128-50-7 
Liquid 
C11H18O 
166.26 
Insoluble 
Miscible 
230 
 
IR NMR 
95 % 
1.490-1.500 
0.965-0.973 
 
Racemate (EFFA, 2010a). 
05.098 
971 
p-Menth-1-en-9-al 
O
3178 
10347 
29548-14-9 
Liquid 
C10H16O 
152.23 
Insoluble 
Miscible 
95 (13 hPa) 
 
NMR 
99 % 
1.458-1.466 
0.904-0.916 
(20°) 
 
Racemate (EFFA, 2010a).  
05.104 
977 
2,6,6-Trimethylcyclohexa-1,3-diene-
1-carbaldehyde 
O
3389 
10383 
116-26-7 
Liquid 
C10H14O 
150.22 
Insoluble 
Miscible 
70 (1 hPa) 
 
NMR 
96 % 
1.525-1.533 
0.968-0.980 
(20°) 
 
 
05.112 
978 
2,6,6-Trimethylcyclohex-1-en-1-
acetaldehyde 
O  
3474 
10338 
472-66-2 
Liquid 
C11H18O 
166.26 
Insoluble 
Miscible 
58 (0.5 hPa) 
 
IR NMR 
92 % 
1.480-1.487 
0.873-0.885 
(20°) 
 
Min. assay (92 %) 
secondary components ß-
cyclocitral (2-3 %), ß-
ionone (0.5-1 %), methyl ß-
homocyclogeranate (2-4 %), 
ethyl ß-homocyclogeranate 
(0.6-1 %) (EFFA, 2010a). 
05.119 
967 
2,2,3-Trimethylcyclopent-3-en-1-yl 
acetaldehyde 
O  
3592 
10325 
4501-58-0 
Liquid 
C10H16O 
152.23 
Insoluble 
Miscible 
75 (137 hPa) 
 
NMR 
99 % 
1.462-1.469 
0.918-0.924 
 
CASrn in Register refers to 
(R)-isomer. 
Register name to be changed 
to (1R) 2,2,3-
Trimethylcyclopent-3-en-1-
yl acetaldehyde. 
05.123 
968 
5-Isopropenyl-2-
methylcyclopentanecarboxaldehyde O
 
3645 
 
55253-28-6 
Liquid 
C10H16O 
152.23 
Insoluble 
Miscible 
80 (14 hPa) 
 
IR 
95 % 
1.501-1.508 
0.940-0.952 
(20°) 
 
 
CASrn in Register refers to 
(1R,2R,5S)-isomer. 
Register name to be changed 
to (1R,2R,5S) 5-
Isopropenyl-2-
methylcyclopentanecarboxal
dehyde. 
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Table 1: Specification Summary of the Substances in the JECFA Flavouring Group of Alicyclic Primary Alcohols, Aldehydes, Acids and Related Esters (JECFA, 2002d) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
08.034 
965 
Cyclohexylacetic acid 
O
OH
 
2347 
34 
5292-21-7 
Solid 
C8H14O2 
142.20 
Slightly soluble 
Miscible 
242 
28-33 
NMR 
98 % 
1.459-1.467 
1.001-1.009 
 
 
08.060 
961 
Cyclohexanecarboxylic acid 
OH
O 3531 
11911 
98-89-5 
Solid 
C7H12O2 
128.17 
Slightly soluble 
Miscible 
232-233 
28-32 
IR NMR 
98 % 
1.516-1.520 
1.029-1.037 
 
 
08.067 
976 
1,2,5,6-Tetrahydrocuminic acid 
OH
O 3731 
 
71298-42-5 
Solid 
C10H16O2 
168.24 
Slightly soluble 
Soluble 
n.a. 
61 
NMR 
95 % 
n.a. 
n.a. 
 
Racemate (EFFA, 2010a).  
09.028 
964 
2-Cyclohexylethyl acetate O
O  
2348 
218 
21722-83-8 
Liquid 
C10H18O2 
170.25 
Insoluble 
Miscible 
211 (996 hPa) 
 
NMR 
98 % 
1.442-1.450 
0.945-0.948 
 
 
09.289 
969 
alpha-Campholene acetate 
O
O
 
3657 
 
36789-59-0 
Liquid 
C12H20O2 
196.29 
Insoluble 
Miscible 
96 (7 hPa) 
 
IR NMR 
98 % 
1.453-1.460 
0.943-0.949 
 
Commercial product (S)-
enantiomer (EFFA, 2010a). 
Synonym (-)-campholenyl 
acetate (EFFA, 2010a). 
Register name to be changed 
to (-)-campholenyl acetate 
or (S)-campholenyl acetate.  
09.488 
966 
Ethyl cyclohexanepropionate 
O
O 2431 
2095 
10094-36-7 
Liquid 
C11H20O2 
184.28 
Insoluble 
Miscible 
91 (10 hPa) 
 
NMR 
98 % 
1.444-1.452 
0.926-0.932 
 
 
09.534 
963 
Ethyl cyclohexanecarboxylate 
O
O
 
3544 
11916 
3289-28-9 
Liquid 
C9H16O2 
156.22 
Insoluble 
Miscible 
82 (16 hPa) 
 
IR NMR 
99 % 
1.447-1.454 
0.966-0.978 
(20°) 
 
 
09.536 
962 
Methyl cyclohexanecarboxylate 
O
O 3568 
11920 
4630-82-4 
Liquid 
C8H14O2 
142.19 
Insoluble 
Miscible 
183 
 
IR NMR 
98 % 
1.439-1.447 
0.990-0.999 
 
 
09.615 
972 
p-Menth-1-en-9-yl acetate 
O
O
3566 
10748 
28839-13-6 
Liquid 
C12H20O2 
196.28 
Insoluble 
Miscible 
228-232 
 
NMR 
97 % 
1.441-1.448 
0.931-0.937 
 
Racemate (EFFA, 2010a).  
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 % ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
Flavouring Group Evaluation 73, Revision 1
 
EFSA Journal 2012;10(3):2638 16
5) At 25°C, if not otherwise stated. 
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TABLE 2: GENOTOXICITY DATA  
Table 2.1: GENOTOXICITY (in vitro) EFSA / FGE.209 (EFSA, 2011d) 
FL-no Chemical Name Test System in vitro  Test Object  Concentrations of Substance 
and Test Conditions  
Result  Reference  Comments  
[05.104] 2,6,6-Trimethylcyclohexa-
1,3-diene-1-carbaldehyde 
Reverse Mutation S. typhimurium TA98, 
TA100, TA1535, TA1537 
and TA102 
1.6, 8, 40, 200, 1000, 5000 
μg/plate   
Negative 4 (Beevers, 
2010b) 
Valid study. First experiment: 
Standard plate ± S9. Toxicity was 
observed in all strains with and 
without S9 at 5000 μg/plate and in 
TA1537 and TA102 with S9 at 1000 
μg/plate. 
S. typhimurium TA98, 
TA100, TA1535, TA1537 
and TA102 
125, 250, 500, 1000, 2000, 
5000 μg/plate 
Negative 4 (Beevers, 
2010b) 
Valid study. Second experiment: 
Standard plate without S9. Toxicity 
was observed at 2000 μg/plate and 
above. 
S. typhimurium TA98, 
TA100, TA1535 
62.5, 125, 250, 500, 1000, 
2000, 5000 μg/plate 
Negative 4 (Beevers, 
2010b) 
Valid study. Second experiment with 
S9 and preincubation: Toxicity was 
observed at 500 μg/plate and above. 
S. typhimurium TA1537 and 
TA102 
62.5, 125, 250, 500, 1000, 
2000 μg/plate 
Negative 4 (Beevers, 
2010b) 
Valid study. Second experiment with 
S9 and preincubation: Toxicity was 
observed at 500 μg/plate and above. 
S. typhimurium TA98, 
TA100, TA1535, TA1537 
and TA102 
15.625, 31.25, 62.5, 125, 250, 
500 μg/plate 
Negative 4 (Beevers, 
2010b) 
Valid study. Third experiment with S9 
and preincubation: Toxicity was 
observed at 250 μg/plate and above.  
Micronucleus 
induction 
Human peripheral blood 
lymphocytes 
0, 40, 60, 90 μg/ml 1 Negative 5 (Whitwell, 
2010c) 
Valid study. 
0, 80, 100, 120, 140 μg/ml 2 
0, 4, 8, 12 μg/ml 3 
1) 3 hours treatment 21 hours recovery without S9. 
2) 3 hours treatment 21 hours recovery with S9. 
3) 24 hours treatment no recovery without S9. 
4) The assays were performed according to OECD guideline 471 and in compliance with GLP. 
5) This assay is performed in accordance with OECD 487.                 
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TABLE 3: SUMMARY OF SAFETY EVALUATIONS 
Table 3.1: Summary of Safety Evaluation of Alicyclic Primary Alcohols, Aldehydes, Acids and Related Esters (JECFA, 2003a) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
02.114 
970 
2-(2,2,3-Trimethylcyclopent-3-
enyl)ethan-1-ol 
OH  
0.012 
ND 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
02.141 
986 
2-(6,6-Dimethylbicyclo[3.1.1]hept-
2-en-2-yl)ethan-1-ol 
OH  
33 
0.01 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
05.098 
971 
p-Menth-1-en-9-al 
O
0.12 
ND 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
05.112 
978 
2,6,6-Trimethylcyclohex-1-en-1-
acetaldehyde 
O  
0.24 
2 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
According to JECFA: 
Min. assay value is "92 
%". Secondary 
components ß-cyclocitral 
(2-3 %), ß-ionone (0.5-1 
%), methyl ß-
homocyclogeranate (2-4 
%), ethyl ß-
homocyclogeranate (0.6-
1 %) (EFFA, 2010a). 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
05.119 
967 
2,2,3-Trimethylcyclopent-3-en-1-yl 
acetaldehyde 
O  
5.0 
ND 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
CASrn in Register refers 
to (R)-isomer. 
Register name to be 
changed to (1R) 2,2,3-
Trimethylcyclopent-3-
en-1-yl acetaldehyde.  
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 3.1: Summary of Safety Evaluation of Alicyclic Primary Alcohols, Aldehydes, Acids and Related Esters (JECFA, 2003a) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
05.123 
968 
5-Isopropenyl-2-
methylcyclopentanecarboxaldehyde O
 
0.012 
ND 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
CASrn in Register refers 
to (1R,2R,5S)-isomer 
Register name to be 
changed to (1R,2R,5S) 5-
Isopropenyl-2-
methylcyclopentanecar-
boxaldehyde.  
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
08.034 
965 
Cyclohexylacetic acid 
O
OH
 
0.12 
0.4 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
as flavouring substance 
based on the MSDI 
approach. 
08.060 
961 
Cyclohexanecarboxylic acid 
OH
O
 
0.061 
4 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
as flavouring substance 
based on the MSDI 
approach. 
08.067 
976 
1,2,5,6-Tetrahydrocuminic acid 
OH
O 0.012 
ND 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.028 
964 
2-Cyclohexylethyl acetate O
O  
0.97 
ND 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
as flavouring substance 
based on the MSDI 
approach. 
09.289 
969 
alpha-Campholene acetate 
O
O
 
0.061 
ND 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
Register name to be 
changed to (-)-
campholenyl acetate or 
(S)-campholenyl acetate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.488 
966 
Ethyl cyclohexanepropionate 
O
O 0.12 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 3.1: Summary of Safety Evaluation of Alicyclic Primary Alcohols, Aldehydes, Acids and Related Esters (JECFA, 2003a) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
09.534 
963 
Ethyl cyclohexanecarboxylate 
O
O
 
0.24 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.536 
962 
Methyl cyclohexanecarboxylate 
O
O
 
0.073 
0.01 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
as flavouring substance 
based on the MSDI 
approach. 
09.615 
972 
p-Menth-1-en-9-yl acetate 
O
O
0.85 
ND 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
05.104 
977 
2,6,6-Trimethylcyclohexa-1,3-
diene-1-carbaldehyde 
O  
3.5 
0.07 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL 
exists 
4) Evaluated in FGE.209, 
genotoxicity concern could 
be ruled out (EFSA, 2011). 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach.  
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
 
ND) Not Determined. 
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Table 3.2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.12Rev2) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation 
remarks 
02.134 
 
2-Cyclohexylethan-1-ol OH 0.011 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.186 
 
Myrtanol 
OH
0.37 
 
Class I 
A3: Intake below threshold 
4) 7)  
05.157 
 
Isocyclocitral 
O
0.011 
 
Class I 
A3: Intake below threshold 
4) 7)  
05.183 
 
4-(2,6,6-
Trimethylcyclohexenyl)-2-
methylbutanal 
O
0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
05.198 
 
alpha-Methyl ional 
O
0.011 
 
Class I 
A3: Intake below threshold 
4) 7)  
08.135 
 
4-(2,2,3-
Trimethylcyclopentyl)butanoic 
acid OH
O
43 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.342 
 
Cyclogeranyl acetate 
O
O 0.24 
 
Class I 
A3: Intake below threshold 
4) 6)  
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Table 3.2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.12Rev2) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation 
remarks 
09.670 
 
Myrtanyl acetate 
O
O
0.58 
 
Class I 
A3: Intake below threshold 
4) 7)  
09.829 
 
Ethyl cyclohexyl acetate O
O
0.61 
 
Class I 
A3: Intake below threshold 
4) 6)  
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
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ABBREVIATIONS 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CHO  Chinese Hamster Ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic Acid 
EFSA  European Food Safety Authority 
EPA  United States Environmental Protection Agency  
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good Laboratory Practise 
ID  Identity 
Ip  Intraperitoneal 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MNBN  Micronucleated binucleate 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NCE  Normochromatic Erythrocyte 
No  Number 
NOAEL No Observed Adverse Effect Level 
NTP  National Toxicology Program 
OECD  The Organisation for Economic Co-operation and Development 
PCE  Polychromatic Erythrocyte 
SCE  Sister Chromatic Exchange 
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SCF  Scientific Committee on Food 
WHO  World Health Organisation 
